Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
107 Leser
Artikel bewerten:
(0)

EQS-News: BaWang Group Announces to Dismiss Appeal against Next Magazine

EQS-News / 23/06/2016 / 19:22 UTC+8 
 
For Immediate Release 
 
/ 
BaWang International (Group) Holding Limited 
 
BaWang Group Announces to Dismiss Appeal against Next Magazine 
* * * 
Product Quality Recognised and Reassured 
Future Focus on Business Development 
 
(23 Jun 2016, Hong Kong) Chinese herbal shampoo and personal care product brand owner BaWang International (Group) 
Holding Limited ("BaWang" or the "Company", stock code: 1338) and its indirect subsidiary, BaWang (Guangzhou) Company 
Limited, announce today that it has filed a request for dismissal of the appeal regarding the libel lawsuit against Next 
Magazine Publishing Ltd. ("Next Magazine"). 
 
Mr. Chen Qiyuan, Chairman of BaWang said, "The judgment handed down by the Court of First Instance on 23 May 2016 
affirmed that "BaWang Shampoo's product safety is supported by scientific research". While it has brought justice to us 
and our products, we are disappointed about the compensation amount which carries no more than symbolic meaning. Such an 
amount by no means matches the corporate and brand reputation lost we have suffered over the course of the last six 
years. Nevertheless, after repeated review and evaluation, the Board of Directors plans to pool its financial resources 
and strengths for business operations and development. We therefore have decided to dismiss the appeal and have 
submitted a request for dismissal to the High Court today." 
 
Mr. Chen Qiyuan added, "Looking ahead, we will make all efforts to consolidate our brand position, and implement a 
balanced strategy of product diversification to become the leader of herbal home and personal care products. We are 
actively exploring new online and offline sales channels. In terms of product sales, we will develop new CS channels and 
launch a new baby care brand in the second half of this year to diversify our product portfolio and attract consumers 
with broadened product lines. Meanwhile, we will also continue to exercise stringent product quality control, reinforce 
our foothold in the Chinese market and strengthen overseas development, with the provision of safe and effective 
personal care products for consumers. 
 
Honourable Lok J of the Court of First Instance of Hong Kong handed down the Judgment in favour of BaWang in respect of 
a libel lawsuit BaWang filed against Next Magazine for its publishing an inaccurate and defamatory report in July 2010. 
Next Magazine was ordered to pay the Company and BaWang Guangzhou, general damages for libel in an aggregate amount of 
HK$3,004,652.50 and 80% of the legal costs of the Company and BaWang Guangzhou in respect of the Legal Proceedings. The 
judgment stated that "Next Magazine had adopted a naïve and unprofessional approach in reporting the story" and that 
Next Magazine's report in the article was "not a product of responsible journalism'. 
 
- End - 
 
About BaWang 
BaWang International (Group) Holding Limited is engaged in the research and development, manufacture and marketing of 
Chinese herbal shampoo and a range of personal care products. The BaWang brand has been awarded the Well-known Trademark 
of China in 2007. According to the research results of Euro monitor International, the BaWang brand has been the leading 
Chinese brand in terms of sales value in the Chinese herbal shampoo and anti-hair-loss shampoo market in the PRC between 
2007 and 2013. 
 
BaWang adopts a multi-brand strategy and operates diversified branded products including BaWang Shampoo, Royal Wind, 
Herborn and Litao. BaWang's distribution network covers 27 provinces and four municipalities in the PRC. Additionally, 
BaWang branded products are sold in Hong Kong, Singapore, Thailand, Malaysia and Australia. 
 
Document: http://n.eqs.com/c/fncls.ssp?u=GRKAHGVBLQ 
Document title: ENG 
 
Key word(s): Miscellaneous 
 
23/06/2016 Dissemination of a Press Release, transmitted by EQS TodayIR - a company of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
Media archive at www.todayir.com 
473843 23/06/2016 
 
 

(END) Dow Jones Newswires

June 23, 2016 07:23 ET (11:23 GMT)

© 2016 Dow Jones News
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.